NO20010804L - Muskariniske agonister og antagonister - Google Patents

Muskariniske agonister og antagonister

Info

Publication number
NO20010804L
NO20010804L NO20010804A NO20010804A NO20010804L NO 20010804 L NO20010804 L NO 20010804L NO 20010804 A NO20010804 A NO 20010804A NO 20010804 A NO20010804 A NO 20010804A NO 20010804 L NO20010804 L NO 20010804L
Authority
NO
Norway
Prior art keywords
antagonists
muscarinic agonists
muscarinic
agonists
Prior art date
Application number
NO20010804A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010804D0 (no
Inventor
Gurmit Grewal
Anna Toy-Palmer
Xiong Cai
George Mark Latham
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of NO20010804D0 publication Critical patent/NO20010804D0/no
Publication of NO20010804L publication Critical patent/NO20010804L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20010804A 1998-08-18 2001-02-16 Muskariniske agonister og antagonister NO20010804L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (2)

Publication Number Publication Date
NO20010804D0 NO20010804D0 (no) 2001-02-16
NO20010804L true NO20010804L (no) 2001-04-11

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010804A NO20010804L (no) 1998-08-18 2001-02-16 Muskariniske agonister og antagonister

Country Status (30)

Country Link
US (5) US6093724A (ru)
EP (1) EP1112272B1 (ru)
JP (1) JP2002523416A (ru)
KR (1) KR20010072784A (ru)
CN (1) CN1312812A (ru)
AR (1) AR020199A1 (ru)
AT (1) ATE227724T1 (ru)
AU (1) AU750566B2 (ru)
BG (1) BG105256A (ru)
BR (1) BR9913072A (ru)
CA (1) CA2340946A1 (ru)
CO (1) CO5130018A1 (ru)
DE (1) DE69903961T2 (ru)
EE (1) EE200100096A (ru)
ES (1) ES2191455T3 (ru)
HK (1) HK1038918A1 (ru)
HU (1) HUP0103203A3 (ru)
ID (1) ID27544A (ru)
IL (1) IL141050A0 (ru)
IS (1) IS5827A (ru)
NO (1) NO20010804L (ru)
NZ (1) NZ509762A (ru)
PE (1) PE20000988A1 (ru)
PL (1) PL346247A1 (ru)
RU (1) RU2219179C2 (ru)
SK (1) SK1892001A3 (ru)
TR (1) TR200100462T2 (ru)
WO (1) WO2000011001A1 (ru)
YU (1) YU13301A (ru)
ZA (1) ZA200100978B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0114697A (pt) * 2000-10-19 2003-11-18 Pfizer Prod Inc Derivados em ponte de piperazina
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) * 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
EP2455383A3 (en) * 2007-03-23 2012-09-19 Abbott Laboratories 4 -substituted azaadamantane derivatives and methods of use thereof
ES2378116T3 (es) * 2007-03-23 2012-04-09 Abbott Laboratories Derivados acetamida y carboxamida de azaadamantano y métodos de uso de los mismos
NZ597511A (en) * 2009-06-19 2014-01-31 Abbvie Inc Diazahomoadamantane derivatives and methods of use thereof
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
WO2011011060A1 (en) 2009-07-22 2011-01-27 Puretech Ventures Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AU2011305462B2 (en) * 2010-09-23 2015-11-26 Abbvie Bahamas Ltd. Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
US11325896B2 (en) 2017-12-20 2022-05-10 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
IL281809B (en) 2018-09-28 2022-09-01 Karuna Therapeutics Inc Compositions and methods for the treatment of diseases improved by the activation of muscarinic receptors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1992011261A1 (en) * 1990-12-21 1992-07-09 Merck Sharp & Dohme Limited 4-azatricyclo[2.2.1.02,6]heptanes and pharmaceutical compositions
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
CZ285571B6 (cs) * 1995-11-02 1999-09-15 Neurosearch A/S Kondenzované tropanové deriváty, způsob jejich výroby, farmaceutické prostředky, které je obsahují a jejich použití k léčení
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
EE200100096A (et) 2002-06-17
US6251916B1 (en) 2001-06-26
RU2219179C2 (ru) 2003-12-20
BR9913072A (pt) 2001-05-15
EP1112272A1 (en) 2001-07-04
BG105256A (en) 2001-11-30
WO2000011001A1 (en) 2000-03-02
ES2191455T3 (es) 2003-09-01
AR020199A1 (es) 2002-05-02
CN1312812A (zh) 2001-09-12
ZA200100978B (en) 2002-02-05
JP2002523416A (ja) 2002-07-30
YU13301A (sh) 2005-06-10
NO20010804D0 (no) 2001-02-16
NZ509762A (en) 2002-12-20
TR200100462T2 (tr) 2001-09-21
US20020045617A1 (en) 2002-04-18
CA2340946A1 (en) 2000-03-02
ATE227724T1 (de) 2002-11-15
PE20000988A1 (es) 2000-09-30
IL141050A0 (en) 2002-02-10
HUP0103203A2 (hu) 2002-01-28
AU5775899A (en) 2000-03-14
US6423842B1 (en) 2002-07-23
HK1038918A1 (zh) 2002-04-04
PL346247A1 (en) 2002-01-28
DE69903961T2 (de) 2003-07-03
CO5130018A1 (es) 2002-02-27
SK1892001A3 (en) 2001-11-06
IS5827A (is) 2001-01-26
US6323194B1 (en) 2001-11-27
EP1112272B1 (en) 2002-11-13
US6555550B1 (en) 2003-04-29
HUP0103203A3 (en) 2002-10-28
DE69903961D1 (de) 2002-12-19
AU750566B2 (en) 2002-07-25
ID27544A (id) 2001-04-12
US6093724A (en) 2000-07-25
KR20010072784A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
DK1076704T3 (da) IL-2-selektive agonister og antagonister
NO20010804D0 (no) Muskariniske agonister og antagonister
NO20032753L (no) Forbindelse og anvendelse derav
NO20004778D0 (no) Amidderivater og nociceptin antagonister
DE69719354D1 (de) Muscarin-antagonisten
ID25977A (id) Popok sekali pakai
ID23076A (id) Popok sekali pakai
DE60031119D1 (de) Richtbohrvorrichtung und -verfahren
DE69918107D1 (de) Ionomere und ionenleitende zusammensetzungen
FI990534A (fi) CT-kuvauslaite
NO20022334L (no) Ny sammensetning og anvendelse
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DE60109148D1 (de) Muscarinagonisten
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO20006488D0 (no) Sammensetning og anvendelse
DE69901430D1 (de) Zentriereinrichtung
DK1112003T3 (da) Ny sammensætning og anvendelse
DE59904577D1 (de) Metallocenkomplexe
DE59914216D1 (de) Prüfsonde-Antriebsvorrichtung
DE69926628D1 (de) Turbidimeterkalibrierung-überprüfungsvorrichtung
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
DE69919457D1 (de) Messtaster
DE69839736D1 (de) Pseudostereophonie-gerät
DE69918215D1 (de) Bauteil-Tragvorrichtung
DE60009931D1 (de) Muscarin-antagonisten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application